Disease/Infection News

RSS

Novel clinical trial fast tracks testing of COVID-19 therapies

A novel clinical trial developed by researchers at the University of Pittsburgh School of Medicine launched today at UPMC to address one of the most important debates during the COVID-19 pandemic:

9 Apr 2020

New guidance on treating COVID-19 patients with heart attack signs

Much remains unknown about COVID-19, but many studies already have indicated that people with cardiovascular disease are at greater risk of COVID-19.

9 Apr 2020

Microneedle patches for potential COVID-19 vaccines or therapeutics

The COVID-19 pandemic is spreading over the world, causing panic and illness on a scale unprecedented in one hundred years. Even while the death toll nears 100,000, with over 1.5 million confirmed cases worldwide, public health experts and medical professionals are battling it using all the weapons available. Unfortunately, these are all too few.

9 Apr 2020

Simplified ventilator for COVID-19 patients designed by particle physicists

An international team of particle physicists have paused their search for dark matter to focus on the needs of victims of the global pandemic -- in particular, their need to breathe.

9 Apr 2020

3D printing silicone for breathing apparatus to help handle the COVID-19 pandemic

The COVID-19 pandemic is exhausting the healthcare resources of many countries, both developed and developing. With the escalating volume of patients who need intensive care and ventilation, breathing masks have become a high-priority item that many medical companies are racing to fill orders for in many parts of the world.

9 Apr 2020

Testing One, Two, Three - Over 75% of people with COVID-19 are asymptomatic

A new study published in the British Medical Journal in April 2020 suggests that the number of people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is astonishingly higher than the number of cases reported so far. This could help shape future social distancing measures.

9 Apr 2020

Weekly COVID-19 fatality predictions from leading epidemiologists

While many developed and developing countries are reeling under the impact of the SARS-CoV-2 virus, which causes COVID-19 disease, preventive and therapeutic measures alike need more accurate forecasts of fatal and non-fatal events to achieve preparedness and ensure an optimal outcome. Now scientists at Imperial College, London, have come up with a new weekly forecast of the number of deaths due to coronavirus and the likely number of cases reported in countries where the virus is actively spreading.

9 Apr 2020

Hypertensive patients on ACE inhibitors and angiotensin receptor blockers may have improved COVID-19 prognosis

Emerging concerns that common antihypertensive treatment approaches with angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) – jointly known as renin-angiotensin-aldosterone system (RAAS) inhibitors – may exert a negative effect in COVID-19 patients are not grounded in scientific evidence, as reported by researchers in a recent review article published in Mayo Clinic Proceedings journal.

9 Apr 2020

‘Baby, I can’t breathe’: America’s first ER doctor to die in heat of COVID-19 battle

At about 5 a.m. on March 19, a New York City ER physician named Frank Gabrin texted a friend about his concerns over the lack of medical supplies at hospitals.

9 Apr 2020

KHN’s ‘What the Health?’: Who will pay for COVID-19 care?

In the absence of clear leadership from the federal government, states and private companies are pursuing their own plans to help Americans cope with the coronavirus pandemic.

9 Apr 2020

University of Utah Health, Intermountain Healthcare launch two clinical trials to treat COVID-19 patients

Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs -hydroxychloroquine (HCQ) and azithromycin - to treat patients with COVID-19 (infection with the novel coronavirus).

9 Apr 2020

Clinical trial to investigate effectiveness of antimalarial drugs for COVID-19 treatment

Washington University School of Medicine in St. Louis is launching a clinical trial for patients hospitalized with COVID-19 at Barnes-Jewish Hospital.

9 Apr 2020

Quantifying the risk among health care providers who intubate COVID-19 patients

A team at the Perelman School of Medicine at the University of Pennsylvania launched the United States component of a global registry that aims to help protect health care providers who intubate patients with COVID-19 and better quantify their risk of developing the disease.

9 Apr 2020

‘Entry Point’ enzyme for COVID-19 higher in COPD patients and smokers

News-Medical speaks to Professor Don Sin on his research into COVID-19 and its effect on smokers and people suffering from COPD.

9 Apr 2020

Metastatic bladder cancer significantly slowed by treating with immunotherapy after chemotherapy

Using immunotherapy immediately after chemotherapy in patients with metastatic bladder cancer slowed cancer progression.

9 Apr 2020

Phylogenetic network analysis provides ‘snapshot’ of COVID-19 origins

Researchers from Cambridge, UK, and Germany have reconstructed the early "evolutionary paths" of COVID-19 in humans - as infection spread from Wuhan out to Europe and North America - using genetic network techniques.

9 Apr 2020

What does recovery from COVID-19 look like? It depends. A pulmonologist explains.

Reports of recovery from serious illness caused by the coronavirus have been trickling in from around the world.

9 Apr 2020

COVID-19 crisis threatens beleaguered assisted living industry

David Aguirre jumped in his truck and drove toward the hospital in the predawn darkness the minute he got the news: His 91-year-old mom was being rushed from her Texas assisted living facility to the emergency room.

9 Apr 2020

Novel coronavirus targets specific secretory cells in the lungs

Viruses attack specific host cells, which can cause chaos in the body. The novel coronavirus, now called severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2 for short, infects respiratory epithelial cells in the lining of the lung, causing difficulty of breathing. The usual cause of death of those who contract the virus is pneumonia and acute respiratory distress syndrome (ARDS). Now, a new study has found that SARS-CoV-2 specifically attack certain progenitor cells called bronchial transient secretory cells in the lungs.

9 Apr 2020

Digital Science and Zhipu.AI collaborate to conduct data challenges, build COVID-19 information portal

Digital Science, a leading technology company serving emergent needs across the research sector, is pleased to announce a partnership with Beijing-based technology company Zhipu.AI to conduct data challenges and collaborate in building a COVID-19 information portal.

9 Apr 2020

Disease/Infection News

Novel clinical trial fast tracks testing of COVID-19 therapies

New guidance on treating COVID-19 patients with heart attack signs

Microneedle patches for potential COVID-19 vaccines or therapeutics

Simplified ventilator for COVID-19 patients designed by particle physicists

3D printing silicone for breathing apparatus to help handle the COVID-19 pandemic

Testing One, Two, Three - Over 75% of people with COVID-19 are asymptomatic

Weekly COVID-19 fatality predictions from leading epidemiologists

Hypertensive patients on ACE inhibitors and angiotensin receptor blockers may have improved COVID-19 prognosis

‘Baby, I can’t breathe’: America’s first ER doctor to die in heat of COVID-19 battle

KHN’s ‘What the Health?’: Who will pay for COVID-19 care?

University of Utah Health, Intermountain Healthcare launch two clinical trials to treat COVID-19 patients

Clinical trial to investigate effectiveness of antimalarial drugs for COVID-19 treatment

Quantifying the risk among health care providers who intubate COVID-19 patients

‘Entry Point’ enzyme for COVID-19 higher in COPD patients and smokers

Metastatic bladder cancer significantly slowed by treating with immunotherapy after chemotherapy

Phylogenetic network analysis provides ‘snapshot’ of COVID-19 origins

What does recovery from COVID-19 look like? It depends. A pulmonologist explains.

COVID-19 crisis threatens beleaguered assisted living industry

Novel coronavirus targets specific secretory cells in the lungs

Digital Science and Zhipu.AI collaborate to conduct data challenges, build COVID-19 information portal

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News